AACR taking applications for SU2C-Cancer Research UK Fellowship

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE AMERICAN ASSOCIATION FOR CANCER RESEARCH is now accepting applications for the Stand Up To Cancer-Cancer Research U.K. Translational Research Fellowship, which will provide up to four grants for postdoctoral or clinical research fellows, each up to $315,000, over a four-year period.

This grant opportunity is provided by SU2C and Cancer Research U.K. and is the first joint research project resulting from the collaboration between the two groups announced in 2012.

The fellowship will provide four years of research support to early-career investigators in the U.S. and U.K. Research projects must be translational in nature and address critical problems in cancer with the potential to deliver benefit to patients.

The proposed work must be performed in two phases, one in the U.S. and one in the U.K. Each phase must be one to three years in length, and the total support period for this fellowship is a maximum of four years.

Project proposals are due by noon ET July 28, via proposalCENTRAL.

For general information on eligibility criteria, the application process, and other details about this grant, visit the AACR website.

YOU MAY BE INTERESTED IN

Acting Director Dr. Krzysztof Ptak’s words reverberated throughout the meeting room—and the heads of several of us—during the National Cancer Institute’s Office of Cancer Centers update on the final day of the 2024 Association of American Cancer Institutes/Cancer Center Administrators Forum Annual Meeting in Chicago.
“Bridge to Bahia” exhibit.Source: Sylvester Comprehensive Cancer CenterKaren Estrada, a survivor of acute myeloid leukemia, used visual art to communicate with her two boys while undergoing a bone marrow transplant at Sylvester Comprehensive Cancer Center. Because Estrada’s treatment required isolation, and her young children could not yet read and write, she sought out other creative vessels to foster closeness between them.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login